Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
12/2000
12/14/2000WO2000075186A1 Neuromedin b and somatostatin receptor agonists
12/14/2000WO2000075180A2 Peptides for vaccinating against human cmv
12/14/2000WO2000075178A1 Novel echinocandin derivatives, method for preparing same and use as antifungal agents
12/14/2000WO2000075177A1 Echinocandin derivatives, method for preparing same and application as antifungal agents
12/14/2000WO2000075176A1 Small cyclic mimics of brain-derived neurotrophic factor (bdnf)
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075174A1 Heart homing peptides and methods of using same
12/14/2000WO2000075173A2 Peptide fragments of colostrinin
12/14/2000WO2000075167A2 Phosphorylation assays
12/14/2000WO2000075164A1 COMPOSITIONS AND METHODS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES
12/14/2000WO2000075162A1 A compound containing a labile disulfide bond
12/14/2000WO2000042063A3 Peptides for inhibiting hbv core proteins
12/14/2000CA2390090A1 Peptides
12/14/2000CA2376729A1 Small cyclic mimics of brain-derived neurotrophic factor (bdnf)
12/14/2000CA2376506A1 Neuromedin b and somatostatin receptor agonists
12/14/2000CA2376490A1 Novel echinocandin derivatives, method for preparing same and use as antifungal agents
12/14/2000CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/13/2000CN1059466C Method for identifying individuals suffering from cellular abnormality
12/12/2000US6160087 Peptides having an amino acid sequence from the fimbrial protein of porphyromonas gingivalis and their uses
12/12/2000US6159937 Immunomodulators
12/12/2000US6159936 Microbiocides or viricides
12/07/2000WO2000073341A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000WO2000073327A1 Chemokine receptor ccr3 antagonists
12/07/2000WO2000073326A2 Redox-stable, non-phosphorylated cyclic peptide inhibitors of sh2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
12/07/2000WO2000072864A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000DE19927039A1 New peptide compounds including Immediate-Early 1 Protein fragments, useful for the production of vaccines against human cytomegaloviruses (HCMV) and diagnostics for the identification of HCMV infections
12/07/2000CA2375657A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000CA2372249A1 Chemokine receptor ccr3 antagonists
12/06/2000EP1057025A1 Protein kinase c
12/06/2000EP1056771A1 Streptogramin derivatives, preparation method and compositions containing same
12/06/2000EP1056468A1 Method of promoting embryonic stem cell proliferation
12/06/2000EP1056465A1 Antimicrobial peptides and derived metapeptides
12/06/2000CN1275576A Human urine anti-tumor (antibacterial) peptide, its preparation and use
12/05/2000US6156731 Enteric overcoating
12/05/2000US6156572 Three dimensional high water content matrix having at least one cellular adhesion molecule covalently immobilized and homogeneously dispersed; facilitates tissue regeneration or replacement
12/05/2000CA2098921C Angiogenic peptides
12/05/2000CA2026655C Process for the solubilisation of peptides and process for the synthesis of peptides
11/2000
11/30/2000WO2000071573A2 Immunogenic peptides derived from mage and the use thereof
11/30/2000WO2000071570A1 Solid phase peptide synthesis method
11/30/2000WO2000071569A1 Minimal isolation peptide synthesis process using ion-exchange resins as scavenging agents
11/30/2000CA2374354A1 Immunogenic peptides derived from mage and the use thereof
11/30/2000CA2373816A1 Minimal isolation peptide synthesis process using ion-exchange resins as scavenging agents
11/29/2000EP1055125A2 Interaction between cyclin d1 and steroid receptor co-activators
11/29/2000EP1054902A1 Agents for the prevention of damages caused by stress conditions
11/29/2000EP1054898A1 Neuroprotective peptides and uses thereof
11/29/2000EP1054689A1 Strategically modified hepatitis b core proteins and their derivatives
11/29/2000EP1054684A1 Method of promoting neuronal cell proliferation and differentiation
11/29/2000EP0629133B1 Peptide-metal ion pharmaceutical applications
11/29/2000CN1275132A Treatmet of obesity
11/28/2000US6153738 Having 6-12 amino acids, preferably including one or more d-tryptophan or d-leucine residues; anticonvulsants, neuroprotective agents
11/28/2000US6153732 Kit for detecting analyte indicative of type II collagen resorption in vivo
11/28/2000US6153587 Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
11/28/2000US6153585 Arylsulfonanilide derivatives
11/28/2000US6153393 Elimination of interference in diagnostic methods by peptides comprising D-amino acids
11/28/2000US6153192 An amino acid sequence consisting of at least 6 contiguous amino acids and no more than 39 contiguous amino acids found at positions 144-183 of human microglobulin; for use in immunoassay to determine human microglobulin in a sample
11/28/2000CA2066428C Structural alterations of the egf receptor gene in human gliomas
11/23/2000WO2000070665A2 Long lasting anti-angiogenic peptides
11/23/2000WO2000070351A2 Protein-protein interactions and methods for identifying them
11/23/2000WO2000069911A1 Long lasting insulinotropic peptides
11/23/2000WO2000069900A2 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
11/23/2000WO2000069891A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069472A2 Enzyme-activated anti-tumor prodrug compounds
11/23/2000WO2000031124A3 Peptides that modulate the interaction of b class ephrins and pdz domains
11/23/2000WO2000026348A3 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
11/23/2000WO2000020441A3 Cyclic peptides as antifungal agents
11/23/2000CA2623458A1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
11/23/2000CA2505617A1 Modified secretin and method of synthesizing thereof
11/23/2000CA2501421A1 Long lasting exendin-4
11/23/2000CA2499211A1 Modified peptides yy and conjugates thereof
11/23/2000CA2372794A1 Protein-protein interactions and methods for identifying interacting proteins and the amino acid sequence at the site of interaction
11/23/2000CA2372304A1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000CA2370245A1 Enzyme-activated anti-tumor prodrug compounds
11/22/2000EP1053249A2 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production
11/22/2000EP1053248A1 Peptide structures and their use in diagnosis of herpes simplex virus type 2
11/22/2000EP1053247A1 Antifungal cyclohexapeptides
11/22/2000EP1053246A1 Beta-sheet mimetics and methods relating to the use thereof
11/22/2000EP1053008A2 Methods of inducing hair growth and coloration
11/22/2000EP1053005A2 Method of promoting keratinocyte proliferation
11/22/2000EP1053004A2 Use of angiotensin analogues for promoting erythropoiesis
11/22/2000EP1053001A1 Novel mixed amylin activity compounds
11/21/2000US6150325 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical compositions
11/21/2000US6150168 Complex containing a binding molecule which non-covalently binds to the nucleic acid and covalently links to a surface ligand and a nuclear ligand; for gene therapy
11/21/2000US6150087 Non-hepatitis a or b virus polypeptide which is capable of illiciting immune response with hepatitus virus antibodies, for the treatment of and prevention of viral infections
11/21/2000CA2203694C Cancer inhibitory peptides
11/21/2000CA2020477C Sustained release formulations of water soluble peptides
11/16/2000WO2000068373A1 Isolating biological modulators from biodiverse gene fragment libraries
11/16/2000WO2000068265A1 Antimicrobial theta defensins and methods of using same
11/16/2000WO2000068263A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000WO2000068256A1 Cephaibols, novel antiparasitics from acremonium tubakii, method for the production and the utilization thereof
11/16/2000WO2000042179A3 Complex-forming proteins
11/16/2000WO2000035887A3 Vitronectin receptor antagonist pharmaceuticals
11/16/2000WO2000023464A3 Zinc finger binding domains for gnn
11/16/2000CA2721199A1 Isolating biological modulators from biodiverse gene fragment libraries
11/16/2000CA2388092A1 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000CA2372821A1 Antimicrobial theta defensins and methods of using same
11/15/2000EP1051483A1 A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof
11/15/2000EP1051433A2 Antimicrobial peptides
11/15/2000EP0658168B1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
11/14/2000US6147187 Major histocompatibility complex proteins; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6146872 Cyclic lipopeptide acylase
1 ... 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 ... 423